Effects of immune checkpoint inhibitors on B cells: relationship to immune-related adverse events.
Publication
, Journal Article
Pisetsky, DS
Published in: Ann Rheum Dis
June 2018
Duke Scholars
Published In
Ann Rheum Dis
DOI
EISSN
1468-2060
Publication Date
June 2018
Volume
77
Issue
6
Start / End Page
795 / 796
Location
England
Related Subject Headings
- Polymyalgia Rheumatica
- Immunologic Factors
- Humans
- B-Lymphocytes
- Autoimmunity
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1107 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Pisetsky, D. S. (2018). Effects of immune checkpoint inhibitors on B cells: relationship to immune-related adverse events. Ann Rheum Dis, 77(6), 795–796. https://doi.org/10.1136/annrheumdis-2018-213561
Pisetsky, David S. “Effects of immune checkpoint inhibitors on B cells: relationship to immune-related adverse events.” Ann Rheum Dis 77, no. 6 (June 2018): 795–96. https://doi.org/10.1136/annrheumdis-2018-213561.
Pisetsky DS. Effects of immune checkpoint inhibitors on B cells: relationship to immune-related adverse events. Ann Rheum Dis. 2018 Jun;77(6):795–6.
Pisetsky, David S. “Effects of immune checkpoint inhibitors on B cells: relationship to immune-related adverse events.” Ann Rheum Dis, vol. 77, no. 6, June 2018, pp. 795–96. Pubmed, doi:10.1136/annrheumdis-2018-213561.
Pisetsky DS. Effects of immune checkpoint inhibitors on B cells: relationship to immune-related adverse events. Ann Rheum Dis. 2018 Jun;77(6):795–796.
Published In
Ann Rheum Dis
DOI
EISSN
1468-2060
Publication Date
June 2018
Volume
77
Issue
6
Start / End Page
795 / 796
Location
England
Related Subject Headings
- Polymyalgia Rheumatica
- Immunologic Factors
- Humans
- B-Lymphocytes
- Autoimmunity
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1107 Immunology